These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28826036)

  • 1. Protective immunity against tuberculosis: what does it look like and how do we find it?
    Huang L; Russell DG
    Curr Opin Immunol; 2017 Oct; 48():44-50. PubMed ID: 28826036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cells and antibodies in the defense against Mycobacterium tuberculosis infection.
    Achkar JM; Chan J; Casadevall A
    Immunol Rev; 2015 Mar; 264(1):167-81. PubMed ID: 25703559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program.
    Izzo AA
    Curr Opin Immunol; 2017 Aug; 47():78-84. PubMed ID: 28750280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of host-pathogen modulators of autophagy during Mycobacterium Tuberculosis infection and therapeutic repercussions.
    Khan A; Jagannath C
    Int Rev Immunol; 2017 Sep; 36(5):271-286. PubMed ID: 28976784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of vaccines against tuberculosis directed by basic immunology.
    Reece ST; Kaufmann SH
    Int J Med Microbiol; 2008 Jan; 298(1-2):143-50. PubMed ID: 17702652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research progress in the field of immunotherapeutic vaccination in human TB and the way ahead.
    Méndez-Samperio P
    Immunotherapy; 2016 Sep; 8(9):987-9. PubMed ID: 27485072
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycobacterium tuberculosis infection and vaccine development.
    Tang J; Yam WC; Chen Z
    Tuberculosis (Edinb); 2016 May; 98():30-41. PubMed ID: 27156616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of Vaccine-Induced Protection against Mycobacterium tuberculosis Revealed in Comparative Analyses of Lymphocyte Populations.
    Kurtz SL; Elkins KL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1096-108. PubMed ID: 26269537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
    Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trained immunity: a new avenue for tuberculosis vaccine development.
    Lerm M; Netea MG
    J Intern Med; 2016 Apr; 279(4):337-46. PubMed ID: 26602369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological consequences of strain variation within the Mycobacterium tuberculosis complex.
    Tientcheu LD; Koch A; Ndengane M; Andoseh G; Kampmann B; Wilkinson RJ
    Eur J Immunol; 2017 Mar; 47(3):432-445. PubMed ID: 28150302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The search for a tuberculosis vaccine: an elusive quest?
    Nagelkerke NJ; de Vlas SJ; Mahendradhata Y; Ottenhoff TH; Borgdorff M
    Tuberculosis (Edinb); 2006 Jan; 86(1):41-6. PubMed ID: 16253559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
    Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R
    Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity without Efficacy of an Adenoviral Tuberculosis Vaccine in a Stringent Mouse Model for Immunotherapy during Treatment.
    Alyahya SA; Nolan ST; Smith CM; Bishai WR; Sadoff J; Lamichhane G
    PLoS One; 2015; 10(5):e0127907. PubMed ID: 25996375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Tuberculosis Vaccine Strategies: Taking Aim at Un-Natural Immunity.
    Jeyanathan M; Yao Y; Afkhami S; Smaill F; Xing Z
    Trends Immunol; 2018 May; 39(5):419-433. PubMed ID: 29429859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the biology of 16 kDa antigen of Mycobacterium tuberculosis: scope in diagnosis, vaccine design and therapy.
    Siddiqui KF; Amir M; Agrewala JN
    Crit Rev Microbiol; 2011 Nov; 37(4):349-57. PubMed ID: 21919701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in understanding the human immune responses to Mycobacterium tuberculosis.
    Barnes PF; Samten B; Shams H; Vankayalapatib R
    Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1():S5-9. PubMed ID: 20006306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case for Antibodies as Mechanistic Correlates of Immunity in Tuberculosis.
    Kawahara JY; Irvine EB; Alter G
    Front Immunol; 2019; 10():996. PubMed ID: 31143177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease.
    Méndez-Samperio P
    Int J Infect Dis; 2010 May; 14(5):e366-71. PubMed ID: 19762261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.